Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The Company is active worldwide.

  • Revenue in EUR (TTM)22.09bn
  • Net income in EUR1.86bn
  • Incorporated2017
  • Employees71.80k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioMerieux SA3.81bn411.30m12.18bn14.65k29.723.1417.273.203.463.4632.0432.800.73561.825.63259,811.607.719.309.5712.3155.7256.5110.4812.381.20236.140.125817.762.398.70-20.956.878.3619.42
Sartorius AG3.32bn83.20m16.04bn13.76k154.744.8630.824.831.221.2248.6638.730.33651.849.34227,432.601.378.211.7311.8343.9550.934.0614.151.132.410.54519.59-18.6616.74-69.747.7419.143.66
Sartorius Stedim Biotech SA2.75bn169.20m18.53bn10.38k106.304.7740.586.751.791.7929.2239.950.41451.758.84257,644.002.6111.873.0415.1241.8250.966.3117.441.032.950.426618.73-20.5318.02-64.658.2821.823.90
Straumann Holding AG2.63bn326.80m19.97bn11.15k61.139.5442.037.611.931.7015.4712.340.7151.764.21222,176.908.9510.6811.8413.6372.7674.9512.5215.151.5513.150.18737.503.9212.08-43.40-2.0411.5410.12
Sonova Holding AG3.86bn639.38m20.25bn18.15k31.777.7022.245.2510.0510.0560.6641.440.63942.356.82199,818.2010.7510.8713.4513.8872.2871.9716.8017.771.0731.440.426835.21-2.985.59-5.845.771.758.20
Koninklijke Philips NV18.04bn-469.00m23.52bn69.28k----33.411.30-0.4847-0.33519.14--------258,972.70--0.3678--0.501342.1843.84-2.590.6049--5.35----1.920.052971.87---5.24--
Coloplast A/S3.53bn666.04m25.04bn16.02k40.1912.0930.127.1022.1022.10117.8673.490.62882.365.911,676,204.0011.8720.4516.1929.6967.5267.9118.8821.730.558710.600.597591.088.518.291.644.4613.155.59
Alcon AG8.86bn1.01bn41.87bn25.32k41.102.1519.624.731.921.9216.7636.590.3271.875.32328,876.303.740.35384.070.386555.3852.7111.441.221.566.680.195581.128.475.74190.75--3.68--
Siemens Healthineers AG22.09bn1.86bn54.07bn71.80k28.862.9317.342.451.661.6619.6916.340.47953.023.86311,126.804.074.885.626.6037.8237.828.509.220.847719.950.479854.89-0.156610.05-25.963.599.6018.98
EssilorLuxottica SA25.83bn2.29bn102.26bn193.69k36.602.6118.883.966.116.1156.7285.660.42453.308.12134,758.403.982.734.883.2162.3461.289.387.520.622430.610.231375.453.6818.586.3716.1516.6114.13
Data as of Nov 05 2024. Currency figures normalised to Siemens Healthineers AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.